rs10401969

This is a intron variant variant in the SUGP1 gene.

GWAS Catalog Trait Associations (34)

Genome-wide significant associations (p < 5×10⁻⁸) from the NHGRI-EBI GWAS Catalog.

total cholesterol measurement

Willer CJ et al. Discovery and refinement of loci associated with lipid levels. Nature Genetics 45(11):1274-1283 (2013)
Allele C
OR 0.14
p 4.0e-77
N 94,595
Large GWAS
European
Allele C
OR 0.14
p 5.0e-75
N 219,941
Large GWAS
multi-ancestry
Allele C
OR 0.06
p 2.0e-10
N 146,492
Large GWAS
East Asian
Allele C
OR 4.74
p 3.0e-38
N 100,184
Large GWAS
European
Hoffmann TJ et al. A large electronic-health-record-based genome-wide study of serum lipids. Nature Genetics 50(3):401-413 (2018)
Allele C
OR
β 0.095
p 3.0e-27
N 94,674
Large GWAS
multi-ancestry
Kulminski AM et al. Quantitative and Qualitative Role of Antagonistic Heterogeneity in Genetics of Blood Lipids. The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences 75(10):1811-1819 (2020)
Allele C
OR 4.53
p 5.0e-15
N 29,902
Large GWAS
European

triglyceride measurement

Allele C
OR 0.12
p 5.0e-71
N 206,044
Large GWAS
multi-ancestry
Allele C
OR 0.03
p 1.0e-10
N 111,909
Large GWAS
multi-ancestry
Allele C
OR 7.83
p 2.0e-29
N 96,598
Large GWAS
European
Hoffmann TJ et al. A large electronic-health-record-based genome-wide study of serum lipids. Nature Genetics 50(3):401-413 (2018)
Allele C
OR 0.10
p 7.0e-38
N 94,674
Large GWAS
multi-ancestry
Willer CJ et al. Discovery and refinement of loci associated with lipid levels. Nature Genetics 45(11):1274-1283 (2013)
Allele C
OR 0.12
p 1.0e-69
N 94,595
Large GWAS
European
Kulminski AM et al. Quantitative and Qualitative Role of Antagonistic Heterogeneity in Genetics of Blood Lipids. The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences 75(10):1811-1819 (2020)
Allele C
OR 8.63
p 2.0e-14
N 29,902
Large GWAS
European

low density lipoprotein cholesterol measurement

Willer CJ et al. Discovery and refinement of loci associated with lipid levels. Nature Genetics 45(11):1274-1283 (2013)
Allele C
OR 0.12
p 3.0e-54
N 94,595
Large GWAS
European
Allele C
OR 0.12
p 6.0e-51
N 205,367
Large GWAS
multi-ancestry
Allele C
OR 3.11
p 7.0e-22
N 95,454
Large GWAS
European
Hoffmann TJ et al. A large electronic-health-record-based genome-wide study of serum lipids. Nature Genetics 50(3):401-413 (2018)
Allele C
OR
β 0.070
p 7.0e-15
N 94,674
Large GWAS
multi-ancestry
Kulminski AM et al. Quantitative and Qualitative Role of Antagonistic Heterogeneity in Genetics of Blood Lipids. The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences 75(10):1811-1819 (2020)
Allele C
OR 2.95
p 3.0e-8
N 29,902
Large GWAS
European
Kathiresan S et al. Common variants at 30 loci contribute to polygenic dyslipidemia. Nature Genetics 41(1):56-65 (2009)
Allele C
OR
β 0.050
p 2.0e-8
N 19,840
Large GWAS
European
Waterworth DM et al. Genetic variants influencing circulating lipid levels and risk of coronary artery disease. Arteriosclerosis, Thrombosis, and Vascular Biology 30(11):2264-76 (2010)
Allele C
OR 0.05
p 1.0e-11
N 17,723
Large GWAS
multi-ancestry

free cholesterol in IDL measurement

Zoodsma M et al. A genetic map of human metabolism across the allele frequency spectrum. Nature Genetics 57(10):2445-2455 (2025)
Allele C
OR 0.04
p 8.0e-31
N 450,015
Large GWAS
multi-ancestry

fatty acid amount, linoleic acid measurement

Karjalainen MK et al. Genome-wide characterization of circulating metabolic biomarkers. Nature 628(8006):130-138 (2024)
Allele T
OR 0.06
p 2.0e-17
N 136,016
Large GWAS
multi-ancestry

protein measurement

Pietzner M et al. Mapping the proteo-genomic convergence of human diseases. Science (new York, N.y.) 374(6569):eabj1541 (2021)
Allele T
OR 0.19
p 2.0e-16
N 10,708
Large GWAS
European

About SUGP1

SF4 is a member of the SURP family of splicing factors.[supplied by OMIM, Sep 2003]

View all SUGP1 variants →

Gene information from NCBI Gene. Variant classifications from ClinVar.

Community Wiki

No community notes yet for this variant. Sign in to start one.

Comments

Sign in to join the discussion.

Loading comments…